Stay updated with the latest agonist news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on agonist topics.
New Delhi [India], April 1 (ANI): The Government of India on Thursday released details on the GLP -1 Drugs' use, risks, and regulation, according to an official press release. Diabetes is a chronic disease that occurs when the pancreas does not produce adequate insulin, or when the body cannot effectively use the insulin it produces, leading to high blood sugar. If left untreated, it can lead to complications like blindness, kidney failure, heart attacks, stroke and lower limb amputation. Also ...Read More >
New Delhi [India], April 1 (ANI): The Government of India on Thursday released details on the GLP -1 Drugs' use, risks, and regulation, according to an official press release. Diabetes is a chronic disease that occurs when the pancreas does not produce adequate insulin, or when the body cannot effectively use the insulin it produces, leading to high blood sugar. If left untreated, it can lead to complications like blindness, kidney failure, heart attacks, stroke and lower limb amputation. Insu ...Read More >
Bengaluru: Bangalore are you tired of trying viral trends and 'magic remedies' from social media to reduce weight? Today's youth want to be healthy, but a lack of correct information often leads them down the wrong path. Obesity is a complex medical condition that cannot be solved by a two-day diet or a viral challenge. What one needs is a scientific and reliable approach. The good news is that modern science now has a solution - called GLP1 RA (glucagon-like-peptide receptor agonist). This is a ...Read More >
New Delhi, Nov 26: The popular glucagon-like peptide-1 (GLP-1) receptor agonists known to help in weight loss as well as manage blood sugar can also protect the kidneys, regardless of diabetes status, finds a study led by an Indian-origin researcher. Originally developed to treat diabetes, GLP-1 receptor agonists have significant benefits in people with and without diabetes, according to the study published in The Lancet Diabetes & Endocrinology. The drug stimulates insulin production and low ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.